
Cannabigerol (CBG) Shows Promise in Alleviating Anxiety Disorders
Cannabigerol (CBG) is emerging as a potential treatment for anxiety disorders, showing promise in preclinical studies and gaining anecdotal support from users
- •CBG is being studied for its potential to manage anxiety disorders
- •Preclinical studies show CBG reduces anxiety-like behaviors in mice
- •CBG interacts with CB1 and CB2 receptors, influencing mood regulation
- •CBG may enhance the effects of other cannabinoids, like CBD
by huile-cbg-anxiete



















